AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

SUTRO BIOPHARMA, INC. Director's Dealing 2021

Aug 11, 2021

34319_dirs_2021-08-11_f79f7167-7645-433e-b997-ba33b92f9f77.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SUTRO BIOPHARMA, INC. (STRO)
CIK: 0001382101
Period of Report: 2021-08-09

Reporting Person: Chung Jane (Chief Commercial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities beneficially held	0	Direct